Aurélien Delluc

The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria

Medha Barbhaiya, Stéphane Zuily, Ray Naden et al. · Arthritis & Rheumatology · 2023 · 431 citations · Full text

Medicine, Internal Medicine, Autoimmunity +15

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Medha Barbhaiya, Stéphane Zuily, Ray Naden et al. · Annals of the Rheumatic Diseases · 2023 · 424 citations · Full text

Life Sciences, Hematology, Internal Medicine +17

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

N. Costedoat‐Chalumeau, Lionel Galicier, O. Aumaître et al. · Annals of the Rheumatic Diseases · 2012 · 206 citations

Medicine, Pharmacology, Pharmacotherapy +15

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism

Benjamin Planquette, Laurent Bertoletti, Anaïs Charles‐Nelson et al. · CHEST Journal · 2021 · 159 citations

Medicine, Pharmacology, Pharmacotherapy +14

Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France

Aurélien Delluc, Cécile Tromeur, Florent Le Ven et al. · Thrombosis and Haemostasis · 2016 · 133 citations

Medicine, Hematology, Surgery +12